RBC Capital downgrades Nanosonics stock rating on weak FY26 guidance

RBC Capital downgraded Nanosonics (ASX:NAN) to Underperform, lowering its price target to AUD4.00, despite the company reporting strong FY25 results. The downgrade is primarily driven by Nanosonics' initial FY26 guidance falling "significantly below consensus," which RBC attributes to factors like tariffs and ongoing expenditures for business growth. RBC justified the action by citing the stock's "expensive valuation" in light of the reduced earnings outlook, prompting significant cuts to its forecasts.

Analysis

RBC Capital has downgraded Nanosonics (ASX:NAN) to Underperform from Sector Perform, concurrently reducing its price target to AUD4.00 from AUD4.50. This action was taken despite the company delivering FY25 results that exceeded both its own guidance and consensus estimates. The primary catalyst for the downgrade is Nanosonics' initial FY26 guidance, which RBC Capital notes is 'significantly below consensus.' The weaker outlook is attributed to the anticipated impact of tariffs and sustained high expenditure necessary to support future business growth. Consequently, RBC has made 'significant cuts' to its forecasts, justifying the downgrade by highlighting the stock's 'expensive valuation' in the context of a now-reduced earnings trajectory.

Key Decisions for Investors

• Investors should weigh the weak FY26 guidance more heavily than the strong FY25 performance, as the forward outlook is the primary driver behind the analyst downgrade and valuation concerns.
• It is critical to monitor the company's future disclosures on the impact of tariffs and the scale of ongoing expenditures, as these are the key factors identified as pressuring the earnings outlook.
• Given the stock's 'expensive valuation' noted by RBC, positions may be vulnerable to further de-rating if the company's reduced earnings profile becomes entrenched.